CMS releases annual spring inpatient rulemaking

On April 19, 2016, CMS issued its annual spring festival of proposed inpatient rulemaking.  This year the PDF weighs in at 378 pages, here.  See 81 Fed Reg 24946, April 27, 2016.

Centers for Medicare & Medicaid Services 42 CFR Parts 405, 412, 413, and 485 [CMS-1655-P] RIN 0938-AS77 Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2017 Rates; Quality Reporting Requirements for Specific Providers; Graduate Medical Education; Hospital Notification Procedures Applicable to Beneficiaries Receiving Observation Services; and Technical Changes Relating to Costs to Organizations and Medicare Cost Reports. 

The new technology add on payments section is a bit longer than usual, and discusses 9 products (including those continuing from last year).  These are the MAGEC spine bracing system, MIRODERM wound matrix, Idarucizumab [Praxbind, anticoagulation reversal], Titan Spine Interbody Device, Andexanet Alfa [factor 10 inhibitor/antidote], Defitelio [Defibrotide], Edwards INTUITY value system, GORE EXCLUDER Iliac Branch Endoprosthesis, and Vistogard (uridine triacetate; for fluorouracil overdose).  Section H, New Technology, begins at page 25031.